 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
The Journal of Neuroscience, January 21, 2004, 24(3):589-591; doi:10.1523/JNEUROSCI.4921-03.2004
Previous Article | Next Article
BRIEF COMMUNICATION
Reduced Serotonin Type 1A Receptor Binding in Panic Disorder
Alexander Neumeister,1 Earle Bain,2 Allison C. Nugent,2 Richard E. Carson,3 Omer Bonne,1 David A. Luckenbaugh,1 William Eckelman,3 Peter Herscovitch,3 Dennis S. Charney,1 * andWayne C. Drevets2 * National Institutes of Health (NIH), National Institute of Mental Health, Mood and Anxiety Disorders Program, 1Section on Experimental Therapeutics, and 2Section on Neuroimaging in Mood and Anxiety Disorders, and 3NIH, Positron Emission Tomography Imaging Center, Bethesda, Maryland 20892-2670
Recent animal models suggest that disturbances in serotonin type-1A receptor (5-HT1AR) function may contribute to chronic anxiety, although it is not clear at all whether such models constitute relevant models for panic disorder (PD) in humans. The selective 5-HT1AR radioligand [18F]trans-4-fluoro-N-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide (FCWAY) permits in vivo assessment of central 5-HT1AR binding using positron emission tomography (PET). We studied 16 unmedicated symptomatic outpatients with PD and 15 matched healthy controls. Seven patients had an additional diagnosis of a current major depressive episode, however PD was the primary diagnosis. A 120 min PET study of 5-HT1AR binding was acquired using a GE Advance scanner in three-dimensional mode. Using quantitative PET image analysis, regional values were obtained for [18F]-FCWAY volume of distribution (DV), corrected for plasma protein binding, and K1, the delivery rate of [18F]-FCWAY from plasma to tissue. MRI scanning was performed using a GE Signa Scanner (3.0 Tesla) to provide an anatomical framework for image analysis and partial volume correction of PET data. PD patients showed lower DV in the anterior cingulate (t = 4.3; p < 0.001), posterior cingulate (t = 4.1; p < 0.001), and raphe (t = 3.1; p = 0.004). Comparing patients with PD, patients with PD and comorbid depression, and healthy controls revealed that DVs did not differ between PD patients and PD patients with comorbid depression, whereas both patient groups differed significantly from controls. These results provide for the first time in vivo evidence for the involvement of 5-HT1ARs in the pathophysiology of PD.
Key words: anxiety; imaging; neuron; neurotransmitter; positron emission tomography; serotonin
Received Nov 3, 2003; revised November 17, 2003; accepted November 20, 2003.
This article has been cited by other articles:
N. M. Goodfellow, M. Benekareddy, V. A. Vaidya, and E. K. Lambe
Layer II/III of the Prefrontal Cortex: Inhibition by the Serotonin 5-HT1A Receptor in Development and Stress
J. Neurosci., August 12, 2009; 29(32): 10094 - 10103.
[Abstract] [Full Text] [PDF]
E. Fakra, L. W. Hyde, A. Gorka, P. M. Fisher, K. E. Munoz, M. Kimak, I. Halder, R. E. Ferrell, S. B. Manuck, and A. R. Hariri
Effects of HTR1A C(-1019)G on Amygdala Reactivity and Trait Anxiety
Arch Gen Psychiatry, January 1, 2009; 66(1): 33 - 40.
[Abstract] [Full Text] [PDF]
M. Storvik, M. Hakkinen, E. Tupala, and J. Tiihonen
5-HT1A Receptors in the Frontal Cortical Brain Areas in Cloninger Type 1 and 2 Alcoholics Measured by Whole-Hemisphere Autoradiography
Alcohol Alcohol., January 1, 2009; 44(1): 2 - 7.
[Abstract] [Full Text] [PDF]
J. R. Nash, P. A. Sargent, E. A. Rabiner, S. D. Hood, S. V. Argyropoulos, J. P. Potokar, P. M. Grasby, and D. J. Nutt
Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study
The British Journal of Psychiatry, September 1, 2008; 193(3): 229 - 234.
[Abstract] [Full Text] [PDF]
T. Rubino, N. Realini, C. Castiglioni, C. Guidali, D. Vigano, E. Marras, S. Petrosino, G. Perletti, M. Maccarrone, V. Di Marzo, et al.
Role in Anxiety Behavior of the Endocannabinoid System in the Prefrontal Cortex
Cereb Cortex, June 1, 2008; 18(6): 1292 - 1301.
[Abstract] [Full Text] [PDF]
O. G. Cameron, G. C. Huang, T. Nichols, R. A. Koeppe, S. Minoshima, D. Rose, and K. A. Frey
Reduced {gamma}-Aminobutyric AcidA-Benzodiazepine Binding Sites in Insular Cortex of Individuals With Panic Disorder
Arch Gen Psychiatry, July 1, 2007; 64(7): 793 - 800.
[Abstract] [Full Text] [PDF]
C. Firk and C. R. Markus
Review: Serotonin by stress interaction: a susceptibility factor for the development of depression?
J Psychopharmacol, July 1, 2007; 21(5): 538 - 544.
[Abstract] [PDF]
R. A. Hurley, R. Fisher, and K. H. Taber
Sudden Onset Panic: Epileptic Aura or Panic Disorder?
J Neuropsychiatry Clin Neurosci, November 1, 2006; 18(4): 436 - 443.
[Full Text] [PDF]
M. Czesak, S. Lemonde, E. A. Peterson, A. Rogaeva, and P. R. Albert
Cell-Specific Repressor or Enhancer Activities of Deaf-1 at a Serotonin 1A Receptor Gene Polymorphism
J. Neurosci., February 8, 2006; 26(6): 1864 - 1871.
[Abstract] [Full Text] [PDF]
T. R. Insel and R. Quirion
Psychiatry as a Clinical Neuroscience Discipline
JAMA, November 2, 2005; 294(17): 2221 - 2224.
[Full Text] [PDF]
U. F. Bailer, G. K. Frank, S. E. Henry, J. C. Price, C. C. Meltzer, L. Weissfeld, C. A. Mathis, W. C. Drevets, A. Wagner, J. Hoge, et al.
Altered Brain Serotonin 5-HT1A Receptor Binding After Recovery From Anorexia Nervosa Measured by Positron Emission Tomography and [Carbonyl11C]WAY-100635
Arch Gen Psychiatry, September 1, 2005; 62(9): 1032 - 1041.
[Abstract] [Full Text] [PDF]
J. A. Gordon, C. O. Lacefield, C. G. Kentros, and R. Hen
State-Dependent Alterations in Hippocampal Oscillations in Serotonin 1A Receptor-Deficient Mice
J. Neurosci., July 13, 2005; 25(28): 6509 - 6519.
[Abstract] [Full Text] [PDF]
P. Osei-Owusu, A. James, J. Crane, and K. E. Scrogin
5-Hydroxytryptamine 1A Receptors in the Paraventricular Nucleus of the Hypothalamus Mediate Oxytocin and Adrenocorticotropin Hormone Release and Some Behavioral Components of the Serotonin Syndrome
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1324 - 1330.
[Abstract] [Full Text] [PDF]
R. V. Parsey, M.-J. Belanger, G. M. Sullivan, N. R. Simpson, M. G. Stabin, R. Van Heertum, and J. J. Mann
Biodistribution and Radiation Dosimetry of 11C-WAY100,635 in Humans
J. Nucl. Med., April 1, 2005; 46(4): 614 - 619.
[Abstract] [Full Text] [PDF]
S. P. David, N. V. Murthy, E. A. Rabiner, M. R. Munafo, E. C. Johnstone, R. Jacob, R. T. Walton, and P. M. Grasby
A Functional Genetic Variation of the Serotonin (5-HT) Transporter Affects 5-HT1A Receptor Binding in Humans
J. Neurosci., March 9, 2005; 25(10): 2586 - 2590.
[Abstract] [Full Text] [PDF]
O. Bonne, E. Bain, A. Neumeister, A. C. Nugent, M. Vythilingam, R. E. Carson, D. A. Luckenbaugh, W. Eckelman, P. Herscovitch, W. C. Drevets, et al.
No Change in Serotonin Type 1A Receptor Binding in Patients With Posttraumatic Stress Disorder
Am J Psychiatry, February 1, 2005; 162(2): 383 - 385.
[Abstract] [Full Text] [PDF]
P. R. Albert and S. Lemonde
5-HT1A Receptors, Gene Repression, and Depression: Guilt by Association
Neuroscientist, December 1, 2004; 10(6): 575 - 593.
[Abstract] [PDF]
R. A. Bantick, A. J. Montgomery, C. J. Bench, T. Choudhry, N. Malek, P. J. McKenna, D. J. Quested, J. F. W. Deakin, and P. M. Grasby
A Positron Emission Tomography Study of the 5-Ht1A Receptor in Schizophrenia and during Clozapine Treatment
J Psychopharmacol, September 1, 2004; 18(3): 346 - 354.
[Abstract] [PDF]
S. J. Bailey and M. Toth
Variability in the Benzodiazepine Response of Serotonin 5-HT1A Receptor Null Mice Displaying Anxiety-Like Phenotype: Evidence for Genetic Modifiers in the 5-HT-Mediated Regulation of GABAA Receptors
J. Neurosci., July 14, 2004; 24(28): 6343 - 6351.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|